Accenture   Report issue

For profit Phase 1 Phase 2
Founded: Dublin Ireland (1989)

Organization Overview

First Clinical Trial
2009
NCT00881946
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Asthma (Phase 1)

Carcinoma, Ovarian Epithelial (Phase 2)

Histiocytosis (Phase 2)

Histiocytosis, Langerhans-Cell (Phase 2)

Nausea (Phase 2)

Neoplasms (Phase 2)

Ovarian Neoplasms (Phase 2)

Postoperative Nausea and Vomiting (Phase 2)

Rosacea (Phase 2)

Vomiting (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 9
  • # of Trial APIs: 9